Artificial technology start-up OpenAI, on September 23, said that an unauthorised individual “compromised” one of its official accounts on social …
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Novo Nordisk's top executive is slated to face a Senate grilling on Tuesday over the high prices of the company's weight loss drug Wegovy and …